Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06580912Phase 2Completed
Phase 2, randomised, double-blind trial in chronic musculoskeletal pain (2 arms), sponsored by University of Florida. Primary endpoints: Participants With 70% or Greater Adherence Based on Self-reported Daily Diary at 12 weeks, Participants With 70% or Greater Adherence Based on Capsule Counts at 12 weeks and 1 more. Started Jan 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06580912.